Home > Minnesota > Minneapolis > Mueting Raasch Group > David Provence Ph.D

David Provence Ph.D

Work in Mueting Raasch Group

Top Rated Family Law Attorney in Minneapolis, MN

Patent, Contracts

111 Third Avenue South, Suite 350, Minneapolis, MN 55401

About
Qualifications
Fees
Articles
Office Info
Colleagues

About David Provence Ph.D

Practice Areas

Patent
Contracts

Education

William Mitchell College of Law, St. Paul, Minnesota
J.D.
- Honors: cum laude
Washington University School of Medicine, St. Louis, Missouri
Ph.D.
- Major: Molecular Microbiology and Microbial Pathogenesis
Lawrence University
B.A.
- Major: Biology
- Honors: cum laude

Qualifications

Bar Admissions

Minnesota
U.S. Patent and Trademark Office

Other Affiliations

American Society for Microbiology
American Association for the Advancement of Science
Association of University Technology Managers
American Intellectual Property Law Association
Minnesota Intellectual Property Law Association

Articles

Published Works

“Anticipating Inherency Issues: To Recognize Or Not To Recognize . . . But . . . Where Does Enablement Fit In?” presented at Advanced Patent Practice CLE sponsored by the Minnesota State Bar Association, Minneapolis, Minnesota, February 2004.
“From Lab to Market: The Challenges of Bringing Research to the Public Through Technology Commercialization,” presented at the College of Veterinary Medicine, University of Minnesota, November 2, 2007.
“Globalization and Implications for Technology Transfer,” Moderator, presented at The Association of University Technology Managers Central Regional Meeting, Cleveland, Ohio, July 2008.
“Patent Law Primer,” presented at The Association of University Technology Managers Central Regional Meeting, Madison, Wisconsin, July 2009.
“Managing Legal Costs: Patent Strategies That Stretch Your Legal Budget,” presented at The Association of University Technology Managers Central Regional Meeting, Memphis, Tennessee, July 2010.
“A Brief Introduction to Patenting Biotech: The Times They Are A-Changin’,” presented at the 2010 BioTechnology Institute Retreat, University of Minnesota, October 6, 2010.
“Commercial Influence on Academic Research and the University Mission,” Moderator, presented at The Association of University Technology Managers Central Regional Meeting, Louisville, Kentucky, July 2011.
Provence, D.L., A. Olsen, and R. Curtiss III, “Preliminary analysis of hemagglutination and fibronectin binding by avian pathogenic Escherichia coli,” Abstract, Gordon Conference on Microbial Toxins and Pathogenesis (1991).
Provence, D.L., and R. Curtiss III, “Role of crl in avian pathogenic Escherichia coli: a knockout mutation of crl does not affect hemagglutination activity, fibronectin binding, or curli production,” Infection and Immunity, 60, 4460-4467 (1992).
Provence, D.L., “Mannose-resistant hemagglutination and fibronectin binding by avian pathogenic Escherichia coli,” Abstract, 92nd Annual Meeting of the American Society for Microbiology (1992).
Provence, D.L., and R. Curtiss III, “Gene transfer in gram-negative bacteria,” In P.Gerhardt (ed.), Methods for General and Molecular Bacteriology pp. 317-347, American Society for Microbiology, Washington D.C. (1993).
Provence, D.L., and R. Curtiss III, “The genetic and molecular basis of hemagglutination by an avian pathogenic Escherichia coli: the putative hemagglutinin has significant homology to the Hemophilus influenzae and Neisseria gonnorrhoeae IgA1 proteinases,” Abstract, Gordon Conference on Molecular Mechanisms of Microbial Adhesion (1993).
Provence, D.L., and R. Curtiss III. “Isolation and characterization of a gene involved in hemagglutination by an avian pathogenic Escherichia coli,” Infection and Immunity, 62, 1369-1380 (1994).
Provence, D.L., and R. Curtiss III. “Secretion of an Escherichia coli protein: similarities to the autosecretory proteins of Hemophilus influenzae and Neisseria gonnorrhoeae,” Abstract, Gordon Conference on Microbial Toxins and Pathogenesis (1994).
Stathopoulos C., D.L. Provence, and R. Curtiss III. “Characterization of the avian pathogenic Escherichia coli hemagglutinin Tsh, a member of the immunoglobulin A protease-type family of autotransporters,” Infection and Immunity, 67, 772-781 (1994).